[1]Patent:US3987052,1976,A
[1]CurrentPatentAssignee:PFIZERINC-US3987052,1976,A
[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US4116956,1978,A
[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US4116956,1978,A
40070-48-2
29113-34-6 | 4-Quinazolone-2-carboxylic Acid | AA002XAJ | MFCD13193857
292169-72-3 | (2Z)-2-(5-Bromo-2-fluorobenzylidene)[1,3]thiazolo[3,2-a]benzimidazol-3(2h)-one | AA002XNU | MFCD02071609
2932-65-2 | 1-(4-Propylphenyl)ethan-1-one | AA002XZ5 | MFCD00063060
29449-73-8 | 2-(Benzyloxy)-6-chloropyridine | AA002YBH | MFCD11976458
29552-52-1 | 4-Ethyl-5-(4-fluorophenyl)-4h-1,2,4-triazole-3-thiol | AA002YNR | MFCD03900771
29679-58-1 | 2-(3-phenoxyphenyl)propanoic acid | AA002Z07 | MFCD00072027
302581-36-8 | 3-Hydroxy-4-((2-hydroxyethyl)amino)tetrahydrothiophene 1,1-dioxide | AA002ZAE | MFCD00456574
3031-98-9 | (3S,4R,5S)-Methyl 3,4,5,6-tetrahydroxy-2-oxohexanoate | AA002ZJO | MFCD23135237
30389-37-8 | Quinoline, 1,2,3,4-tetrahydro-5-methoxy- | AA002ZVO | MFCD09026772
304680-35-1 | 1-Hexyl-3-methylimidazolium hexafluorophosphate | AA003057 | MFCD03093296